Cytosorbents Corp — Director's Dealing 2017

Jun 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2017-06-08

Reporting Person: Chan Phillip P. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-08	Common Stock	P	3700	$4.00	Acquired	399907	Direct

Footnotes

F1: Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 18,700 RSUs granted on February 24, 2017, (b) 57,000 RSUs granted on June 7, 2016, and (c) 130,000 RSUs granted on April 8, 2015, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 40,625 RSUs granted on February 24, 2017 and (b) 26,000 RSUs granted on June 7, 2016 and (iii) 127,582 shares of common stock owned by the reporting person (including 3,700 shares of common stock purchased in the open market on June 8, 2017 and reported on this Form 4).